Abcely
PrivateLast Round
Seed
Sep 22, 2023
Total Funding Raised
$2.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Abcely operates in Healthcare & Life Sciences and is based in Nantes. Its latest recorded funding round was a Seed round in September 2023.
Abcely is a biotechnology company developing a proprietary platform for orally active sIgA-based immunotherapy to treat mucosal cancers and chronic mucosal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abcely Comparables
Compare Abcely with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mage Biologics Inc. | 78% | |
| Epsilogen | 77% | |
| Sorriso Therapeutics | 72% |
For institutional investors. Book with your work email.
Abcely Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abcely Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MATWIN | Seed |
| GO Capital | Seed |
| Angels Santé | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 306% MoM, reaching 2.1K.
- Sep 22, 2023
$2.6M round from GO Capital and 3Biotech
For institutional investors. Book with your work email.
Abcely Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abcely's valuation, stock price, and market status.
Is Abcely a public or private company?
Abcely is a private company.
What is the current stock price of Abcely?
Abcely is a private company, so its shares have no public market price. Caplight tracks Abcely's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abcely worth (valuation)?
Valuation information for Abcely is not publicly available.
Can I buy Abcely stock?
Abcely shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abcely's last funding round?
Abcely's most recent funding round was Seed on September 22, 2023.
Who are the main investors in Abcely?
Key investors in Abcely include MATWIN, GO Capital, Angels Santé.
Will Abcely IPO soon?
No public IPO plans have been announced for Abcely.
How can I track Abcely secondary market activity?
Caplight tracks bids, offers, and trades in Abcely's shares on secondary markets.